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in comparing interventions across diseases. METHODS:
Cost effectiveness ratios (CERs), presenting the ﬁnancial
cost per quality-adjusted life year saved, enable decision
makers to assess the value of health care products/services
in reducing misery as well as extending life. Although
CERs are valuable especially in comparing options for 
a given disease, decision makers have struggled in using
them to compare the value of alternatives across diseases.
For example, Garvey (2000) noted that the CER use of
sildenaﬁl in erectile dysfunction was favorable compared
with treatments in other diseases, such as renal dialysis
and coronary artery-bypass graft surgery in current liter-
ature. Garvey concluded that while the CER comparisons
were valid on the “local” (condition-speciﬁc) compari-
sons, they are problematic in “global” comparison across
diseases. This could be attributed to the failure of CER
to account for different degrees of medical necessity, base-
line utility, public health importance, and other relevant
issues. Manifold theory helps address the issues arising
from global versus local properties from a geometric 
perspective. Manifold theory provides an excellent 
mathematical model to develop a global, cost-effective
based valuation of interventions that can incorporate
dimensions, such as medical necessity while preserving
the local functionality of useful condition-speciﬁc CER
comparisons. RESULTS: Examples of two different man-
ifolds derived under different assumptions are presented.
The development of the ﬁrst manifold is derived via the-
oretical criteria for rational health resource allocation,
while the second manifold is based on empirical data that
infer “rules at work” in the decision-making coverage for
the U.S. Medicare system. Calculations of global valua-
tions for renal dialysis, cholesterol-lowering medication
and coronary artery bypass graft surgery are presented
and compared to that of sildenaﬁl. CONCLUSIONS: The
resultant values, presented side-by-side with published
CER’s present a more globally interpretable “valuation”.
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OBJECTIVES: Informal care, deﬁned as care provided by
family members or friends, plays a substantial role in the
total care provided to patients with chronic and terminal
diseases. It should be incorporated in any economic eval-
uation adopting the societal perspective. In practice
however, informal care is often neglected. Time is a sub-
stantial part of informal care. The time spent on caring
should be valued to incorporate it in economic evalua-
tions. It is recommended to value informal care time with
the opportunity cost method. We discuss the practical
problems of the application of the opportunity cost
method in caregiving for stroke and rheumatoid arthritis
patients. METHODS: The data for this study are col-
lected by mailed surveys to 217 informal caregivers of
stroke patients and to 153 informal caregivers of rheuma-
toid arthritis patients. RESULTS: We distinguished three
types of forgone time: paid work, unpaid work and
leisure. Informal care is usually at the cost of leisure (60
percent). In stroke however it is also for a major part at
the cost of unpaid work (36 percent). The total amount
of time forgone is in both populations approximately 5
hours a week of unpaid work and in case of stroke more
than 10 hours a week of paid work. The leisure time
forgone in rheumatoid arthritis is twice the leisure time
forgone in stroke. It is worth noting that we developed 
a new instrument to measure the opportunity costs of
informal care to rheumatoid arthritis. CONCLUSIONS:
Rheumatoid arthritis is an inﬂammatory progressive
chronic disease without a clear reference point. A 
reference point means that there is a clear period before
the incidence of the illness and a clear period after the
incidence. This lack of a reference point has important
implications for the measurement of time forgone in order
to be able to provide informal care.
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OBJECTIVES: The suitability and the practicality of
using different data sources in economic evaluation have
been well documented. The objective of this study was 
to identify any trends in the types of data sources used 
in these studies over a 6-year period (1995–2000)
METHODS: For this preliminary study, the area of heart
disease was selected to create a sample of papers for
analysis. A simple search strategy was constructed and
run on the NHS EED database. The retrieved studies were
then sorted by year and type of economic evaluation. The
sources of data used to estimate effectiveness, resource
use and costs for the interventions or programmes in the
studies were then identiﬁed for each study. RESULTS:
The literature search retrieved 326 economic evaluations
published between 1995 and 2000. Data used in the eval-
uations ranged from solely expert opinion to pragmatic
trials where cost and resource use information were 
collected alongside one another. There is a downward
trend in the proportion of studies using a retrospective
analysis to establish the effectiveness of interventions and
programmes. A review of the literature (with no meta-
analysis) has remained a constant data source for effec-
tiveness, accounting for approximately a quarter of all
evaluations each year. The type of resource utilisation
data used has not changed over the years, with the 
majority of information collected alongside trials, with
either the whole study population or with smaller
cohorts, or a retrospective analysis of case notes. The
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documentation of cost data sources has improved over
the six years, and the use of previously published data has
decreased also. CONCLUSIONS: This preliminary study
reveals deﬁnite trends in the different data sources used
in economic evaluation over this six-year period. Whether
these trends can be seen regardless of disease area and
type of intervention remains to be investigated.
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OBJECTIVES: In a paper in the Journal of Health 
Economics, Victor Fuchs (2000) stated that one of the
main research tasks for health economists is to enhance
our understanding of economic behaviour. One of the
areas that are especially important for health economics
as a behavioural science is that, contrary to traditionally
assumed, people appear to be more concerned about 
relative than absolute levels of outcomes. METHODS:
First of all, in surveys of the relation between income and
wealth it was found that people take the behaviour and
wealth of relevant others as reference and, by the desire
to “live up to the Joneses”, adapt their preferences
according to this norm (i.e., “reference drift”). In addi-
tion, this “wealth” norm is affected by habituation to the
status quo individuals have already achieved. Each time
an aspiration level is reached, the norm is raised (i.e.,
“preference drift” or “adaptive preferences”). Is the same
true for health? Do people relate their health state, right
to health and health care to what is viewed as “normal”
or is possible in view of relevant others’ health?
RESULTS: Results from two surveys undertaken among
people from the general public (n = 220 & n = 394)
demonstrate that people adapt their expectations of
length and future quality of life to own health behaviour
relative to that of others and to age and health status of
close relatives. CONCLUSION: Therefore, after JS Mill,
people do not only desire to be healthy, but also as
healthy as others.
METHODOLOGY ISSUES—Quality of Life,
Evaluation, & Productivity Study Issues
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OBJECTIVES: A series of quality of life special interest
groups were set up by ISPOR in 1999 in order to stimu-
late discussion and contribute to the advancement of
science. The translation and cultural adaptation group
has met four times and has been working towards 
the development of a set of principles of best practice.
METHODS: The approach reviews and builds upon
current practice, taking account of existing guidelines and
theoretical perspectives. These diverse perspectives have
been evaluated with regard to the issues and challenges
facing industry and the broader outcomes research com-
munity. This approach seeks to be inclusive, taking into
account the views of practitioners, academics, and users
of health outcome measures. This ﬁrst stage has resulted
in an interim report describing the broadly agreed prin-
ciples of best practice. The next step will involve broad
consultation with practitioners, academics and users in
order to reﬁne and develop the interim report. This report
will set out objectives and principles and identify 
examples of best practice illustrated through a series of 
exemplary case studies. RESULTS: The initial draft of 
the paper is based upon a synthesis of methodological
approaches, common nomenclature, and quality-control
assurance requirements used by the range of organiza-
tions. The interim report provides both methods and
rationale for an expansive list of situations that are now
encountered with regularity. It also includes special pro-
tocols for a variety of unique considerations that have
arisen for translation/adaptation work that is sensitive to
expanding needs and challenges of outcomes research in
ever-expanding global applications. CONCLUSION:
This interim report provides a wealth of information and
guidance for Best Practice Principles in Cross-Cultural
Translation/Adaptation work. It is hoped that the 
presentation at this meeting will provide the starting 
point for the broader review so that a complete range of
perspectives can be taken into account.
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OBJECTIVE: Health economists developed QALYs in the
1970s as an outcome measure combining duration and
quality of life, primarily for use in cost-effectiveness
studies. The concept of the DALY, as developed for the
Global Burden of Disease (GBD) 1990 study, closely
resembled the QALY. We identiﬁed the analogies and dis-
parities of QALYs and DALYs from the literature and our
own empirical experience with both approaches (EQ-5D,
Dutch Disability Weights study). METHODS: The DALY
is a gap measure, deﬁning health loss from some prede-
ﬁned standard, whereas QALYs quantify health gains.
The general approach to derive QALY values includes
empirical valuation of generic health state descriptions,
